基本信息
views: 6
Career Trajectory
Bio
The research in the Kohn lab focuses on the development of new methods to treated genetic diseases of blood cells by gene modification of hematopoietic stem cells. Dr. Kohn’s group was the first (and still the only one) to perform a clinical trial with gene transfer to umbilical cord blood CD34+ cells for a genetic disorder (ADA-SCID in 1993) and the first in the U.S. to initiate clinical trials of gene therapy for pediatric HIV/AIDS using bone marrow stem cells. Current projects include (1) performing clinical trials for ADA-deficient SCID, XSCID, Sickle Cell Disease and X-linked Chronic Granulomatous Disease, (2) developing new lentiviral vectors for regulated gene expression, (3) advancing techniques for site-specific gene editing for sickle cell disease and primary immune deficiency diseases, and (4) improving clinical hematopoietic stem cell processing. Our research group spans the bench-to-bedside spectrum and provides an excellent training environment for physician/scientists.
Research Interests
Papers共 738 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
The Journal of allergy and clinical immunologyno. 5 (2024): 1423-1431.e2
Clinical Immunology (2024): 110111
Bruce Teter,Jesus Campagna,Chunni Zhu, Grace E. McCauley,Patricia Spilman,Donald B. Kohn,Varghese John
biorxiv(2024)
Crystal L Mackall,Catherine M Bollard, Nancy Goodman, Casey Carr,Rebecca Gardner,Rayne Rouce,Elena Sotillo, Rich Stoner,Fyodor D Urnov,Alan S Wayne,Julie Park,Donald B Kohn
Nature medicineno. 7 (2024): 1836-1846
Gene therapyno. 10-11 (2023): 738-746
crossref(2023)
Load More
Author Statistics
#Papers: 740
#Citation: 26807
H-Index: 87
G-Index: 148
Sociability: 8
Diversity: 3
Activity: 103
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn